After 14 years at Lundbeck, Chief Financial Officer Anders Götzsche will depart the Danish pharmaceutical firm no later than May 2022. He is set to join another, as of yet undisclosed, unlisted Danish company.
Deborah Dunsire, CEO at Lundbeck, expects to be able to announce where Götzsche is headed soon. However, it is safe to say that it isn't to one of Lundbeck's competitors, she tells MedWatch.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.